• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Peloton Has Disappointed: Take Your Leave and Sell

We're checking in on the PTON charts again.
By BRUCE KAMICH
Mar 24, 2021 | 09:33 AM EDT
Stocks quotes in this article: PTON

Callers into Tuesday's Mad Money program kept Jim Cramer busy during the Lightning Round segment. One caller  asked Cramer about his thoughts on Peloton (PTON) . "They have done acquisitions in an attempt to diversify, but they've had a big run. I'm moving on."

The last time we wrote about PTON was on March 9, where we wrote that "March 5th was the low day on PTON and today we may well see a close above the high of the low day. This is a quick-turning reversal pattern on bar charts. Aggressive traders could go long PTON here and risk a new low close."

Let's check on the charts again today. 

In the daily Japanese candlestick chart of PTON, below, we see a mixed picture. The shares have tested the rising 200-day moving average line a few times this month. The line has held so far but that may not last. The trading volume has not increased significantly on these tests suggesting that technically oriented buyers are not stepping up aggressively.

The On-Balance-Volume (OBV) line has drifted lower from late December as there appears to be a slight increase in selling. The Moving Average Convergence Divergence (MACD) oscillator moved below the zero line in February for an outright sell signal and only now shows a tepid cover shorts buy signal. 

 
 
In the weekly Japanese candlestick chart of PTON, below, we see a mixed picture. Prices are holding around the rising 40-week moving average line. Trading volume has been light so it seems like traders do not consider this test of the 40-week line as a buying opportunity.
 
The weekly OBV line is still neutral at best. The MACD oscillator is in a bearish alignment.  
 
 
 
In this daily Point and Figure chart of PTON, below, we can see a potential downside price target in the $86 area. 
 
 
 
Bottom-line strategy: Traders who went long on March 9 as a result of our recommendation should now take profits and sell. The anticipated rebound has not worked out and the Point and Figure chart suggests a further decline is possible.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Mad Money | Consumer Discretionary

More from Stocks

Market's 'Superficial' Highs Are Only Skin Dip

James "Rev Shark" DePorre
Apr 9, 2021 4:36 PM EDT

You can't call this market overbought when so much of it isn't participating.

Pinterest: Double Top or Breakout Pending?

Bruce Kamich
Apr 9, 2021 3:00 PM EDT

What would I do in this case? Here's the logical choice.

I'm Continuing to Build a Position in Skillz

Timothy Collins
Apr 9, 2021 2:24 PM EDT

SKLZ shows explosion moves to the upside when it emerges from the oversold area.

Royalty Pharma Shows Promise

Bruce Kamich
Apr 9, 2021 1:10 PM EDT

Here's how traders should play RPRX right now.

Making the Best of the Peculiar Market Action

James "Rev Shark" DePorre
Apr 9, 2021 12:17 PM EDT

Trading in biotech stocks and a particular SPAC play are on my mind.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • 08:05 AM EDT BOB LANG

    Bitcoin vs. Gold: Which Should You Invest In Now?

    Read my article TheStreet here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login